CPHI & PMEC China brings together suppliers and buyers from across the entire pharmaceutical supply chain, offering a unique platform to source, connect, and build partnerships at global scale. With more than 110,000 attendees and 3,600 exhibitors expected in 2026, the event spans pharma ingredients, biotech, contract services, excipients, and finished dosage, making it a central meeting point for modern drug development in China and beyond.
At this year’s event, Ypsomed will highlight approved combination products already on the Chinese market and share insights into our Changzhou manufacturing site. The focus will be on how local production, established platforms, and market experience support reliable supply and long-term collaboration in a fast-moving pharma landscape.
An opportunity in Shanghai to connect around local presence, proven solutions, and the next phase of growth in China’s pharma market.
